OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
278280$47900.0058

Chunbo Co Ltd

Commodity ChemicalsVerified

Chunbo Co Ltd's capital structure is characterized by a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. The company's liquidity position is concerning, with a current ratio of 0.39 and negative cash and equivalents of -68.5 million KRW. Despite a positive operating cash flow of 8.03 billion KRW, the company's free cash flow is negative at -59.08 billion KRW, reflecting significant capital expenditures of -21.61 billion KRW. Profitability metrics show a stark underperformance relative to industry norms. The company reported a net loss of 57.77 billion KRW, with a return on equity of -13.64% and a return on assets of -6.80%. Gross profit of 13.44 billion KRW and operating income of 14.89 billion KRW are insufficient to offset the net loss, suggesting operational inefficiencies or cost overruns. Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration is likely within the South Korean market given its listing and operational base. No specific segments are disclosed, which limits visibility into diversification or risk distribution. The company's growth trajectory is mixed. Revenue for the latest period was 133.85 billion KRW, but the net loss indicates a lack of profitability. Analysts have set a mean price target of 65,400 KRW, suggesting potential upside from the current market price of 47,900 KRW. However, the negative free cash flow and high capital expenditures may constrain near-term growth. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The company's negative net cash position raises concerns about its ability to meet short-term obligations. No recent filings or transcripts are available to provide additional context on strategic initiatives or operational changes. Recent analyst estimates indicate a cautiously optimistic outlook, with a mean recommendation of 2.14 (leaning toward "hold") and a median price target of 60,000 KRW. The disparity between the high and low price targets (79,000 KRW to 51,000 KRW) reflects uncertainty among analysts regarding the company's future performance.

30-day price · 278280-6850.00 (-13.0%)
Low$45000.00High$70700.00Close$45850.00As of20 May, 00:00 UTC
Profile
CompanyChunbo Co Ltd
Ticker278280.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Chunbo Co Ltd is a South Korean company engaged in the production and sale of commodity chemicals, primarily serving the basic materials sector.

Classification. Chunbo Co Ltd is classified under the Commodity Chemicals industry within the Basic Materials economic sector, with a confidence level of 0.92.

Chunbo Co Ltd's capital structure is characterized by a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. The company's liquidity position is concerning, with a current ratio of 0.39 and negative cash and equivalents of -68.5 million KRW. Despite a positive operating cash flow of 8.03 billion KRW, the company's free cash flow is negative at -59.08 billion KRW, reflecting significant capital expenditures of -21.61 billion KRW. Profitability metrics show a stark underperformance relative to industry norms. The company reported a net loss of 57.77 billion KRW, with a return on equity of -13.64% and a return on assets of -6.80%. Gross profit of 13.44 billion KRW and operating income of 14.89 billion KRW are insufficient to offset the net loss, suggesting operational inefficiencies or cost overruns. Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration is likely within the South Korean market given its listing and operational base. No specific segments are disclosed, which limits visibility into diversification or risk distribution. The company's growth trajectory is mixed. Revenue for the latest period was 133.85 billion KRW, but the net loss indicates a lack of profitability. Analysts have set a mean price target of 65,400 KRW, suggesting potential upside from the current market price of 47,900 KRW. However, the negative free cash flow and high capital expenditures may constrain near-term growth. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The company's negative net cash position raises concerns about its ability to meet short-term obligations. No recent filings or transcripts are available to provide additional context on strategic initiatives or operational changes. Recent analyst estimates indicate a cautiously optimistic outlook, with a mean recommendation of 2.14 (leaning toward "hold") and a median price target of 60,000 KRW. The disparity between the high and low price targets (79,000 KRW to 51,000 KRW) reflects uncertainty among analysts regarding the company's future performance.
Key takeaways
  • Chunbo Co Ltd is operating at a net loss despite positive operating cash flow, indicating significant cost pressures or capital outflows.
  • The company's liquidity position is weak, with a current ratio of 0.39 and negative cash and equivalents.
  • Analysts are cautiously optimistic, with a mean price target of 65,400 KRW, but the wide range of price targets suggests uncertainty.
  • The company's debt-to-equity ratio of 0.64 suggests moderate leverage, but the negative free cash flow may limit its ability to service debt.
  • No specific segments or geographic breakdowns are disclosed, limiting visibility into diversification and risk exposure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$133.85B
Gross profit$13.44B
Operating income$14.89B
Net income-$57.77B
R&D
SG&A
D&A
SBC
Operating cash flow$8.03B
CapEx-$21.61B
Free cash flow-$59.08B
Total assets$849.54B
Total liabilities$426.00B
Total equity$423.55B
Cash & equivalents-$68.5M
Long-term debt$271.39B
Valuation
Market price$47900.00
Market cap$556.71B
Enterprise value$828.17B
P/E
Reported non-GAAP P/E
EV/Revenue6.2
EV/Op income55.6
EV/OCF103.1
P/B1.3
P/Tangible book1.3
Tangible book$423.55B
Net cash-$271.46B
Current ratio0.4
Debt/Equity0.6
ROA-6.8%
ROE-13.6%
Cash conversion-14.0%
CapEx/Revenue-16.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric278280Activity
Op margin11.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin-43.2%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin10.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-16.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity64.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Mean price target65,400.00 KRW
Median price target60,000.00 KRW
High price target79,000.00 KRW
Low price target51,000.00 KRW
Mean recommendation2.14 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count0.00
Hold count4.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-478.48 KRW
Last actual EPS-5,752.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 00:42 UTCJob: b6009fa3